Skip to main content
Clinical Trials/ACTRN12614000991617
ACTRN12614000991617
Not yet recruiting
Not Applicable

An investigation of the effects of intranasal oxytocin spray on socio-emotional brain regions in participants with Body Dysmorphic Disorder.

Prof Susan Rossell0 sites64 target enrollmentSeptember 15, 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Prof Susan Rossell
Enrollment
64
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 15, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Prof Susan Rossell

Eligibility Criteria

Inclusion Criteria

  • For Healthy controls: Right\-handed; between the ages of 18\-65 years; non\-smoker and no drug/alcohol abuse; medication free; no neurological disorders, and no metal objects present in body (or which can't be removed or which is not MRI safe). Women who have not experienced menopause.
  • For Body Dysmorphic Disorder (BDD): As above plus a diagnosis of the disorder is required.

Exclusion Criteria

  • Clinically significant medical or neurological condition (other than BDD for the patients), significant head injury (or loss of consciousness from longer than 5 mins), presence of ferrous\-containing metals within the body, inability to tolerate small enclosed spaces without anxiety.

Outcomes

Primary Outcomes

Not specified

Similar Trials